Terms: = Gastric cancer AND HER1, YOR227W AND Prognosis
10 results:
1. Lapatinib.
Voigtlaender M; Schneider-Merck T; Trepel M
Recent Results Cancer Res; 2018; 211():19-44. PubMed ID: 30069757
[TBL] [Abstract] [Full Text] [Related]
2. Expression and prognostic significance of human epidermal growth factor receptors 1, 2 and 3 in oesophageal and gastric adenocarcinomas preneoadjuvant and postneoadjuvant treatment.
Hedner C; Borg D; Nodin B; Karnevi E; Jirström K; Eberhard J
J Clin Pathol; 2018 May; 71(5):451-462. PubMed ID: 29138285
[TBL] [Abstract] [Full Text] [Related]
3. Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1 and 3 in gastric and Esophageal Adenocarcinoma.
Hedner C; Borg D; Nodin B; Karnevi E; Jirström K; Eberhard J
PLoS One; 2016; 11(2):e0148101. PubMed ID: 26844548
[TBL] [Abstract] [Full Text] [Related]
4. Lapatinib.
Nolting M; Schneider-Merck T; Trepel M
Recent Results Cancer Res; 2014; 201():125-43. PubMed ID: 24756789
[TBL] [Abstract] [Full Text] [Related]
5. EGFR, HER-2 and KRAS in canine gastric epithelial tumors: a potential human model?
Terragni R; Casadei Gardini A; Sabattini S; Bettini G; Amadori D; Talamonti C; Vignoli M; Capelli L; Saunders JH; Ricci M; Ulivi P
PLoS One; 2014; 9(1):e85388. PubMed ID: 24454858
[TBL] [Abstract] [Full Text] [Related]
6. Association of her1 amplification with poor prognosis in well differentiated gastric carcinomas.
Kandel C; Leclair F; Bou-Hanna C; Laboisse CL; Mosnier JF
J Clin Pathol; 2014 Apr; 67(4):307-12. PubMed ID: 24218028
[TBL] [Abstract] [Full Text] [Related]
7. [Clinical significance of human epidermal growth factor receptor family molecules expression in gastric cancer].
Li G; Gu RM; Wen X; Ming XZ; Xia L; Xu XY; Zhang J; Chen HQ
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jul; 16(7):668-72. PubMed ID: 23888453
[TBL] [Abstract] [Full Text] [Related]
8. A novel proteomics-based clinical diagnostics technology identifies heterogeneity in activated signaling pathways in gastric cancers.
Lee J; Kim S; Kim P; Liu X; Lee T; Kim KM; Do IG; Park JO; Park SH; Jang J; Hoe N; Harvie G; Kuller A; Jain A; Meyer G; Leesman G; Park YS; Choi MG; Sohn TS; Bae JM; Lim HY; Singh S; Kang WK
PLoS One; 2013; 8(1):e54644. PubMed ID: 23372746
[TBL] [Abstract] [Full Text] [Related]
9. High expression of HER3 is associated with a decreased survival in gastric cancer.
Hayashi M; Inokuchi M; Takagi Y; Yamada H; Kojima K; Kumagai J; Kawano T; Sugihara K
Clin Cancer Res; 2008 Dec; 14(23):7843-9. PubMed ID: 19047113
[TBL] [Abstract] [Full Text] [Related]
10. Clinical significance of the epidermal growth factor receptor and HER2 receptor in resectable gastric cancer.
García I; Vizoso F; Martín A; Sanz L; Abdel-Lah O; Raigoso P; García-Muñiz JL
Ann Surg Oncol; 2003 Apr; 10(3):234-41. PubMed ID: 12679307
[TBL] [Abstract] [Full Text] [Related]